Detection of 4-aminocarminic acid in beverages and cake glaze from the German market: a food additive not approved in the EU

In the European Union, carminic acid and its ammonium, calcium, potassium or sodium salts and its aluminium lakes are approved as food additive E120. In beverages obtained from the German market 4-aminocarminic acid (“acid-stable carmine”) was detected by HPLC–PDA and LC–MS/MS. Isolation of the colorant from a liquid dye preparation used for the production of a beverage sample and subsequent NMR analysis confirmed the presence of 4-aminocarminic acid. Synthesis of ¹⁵N-4-aminocarminic acid clearly demonstrated that “acid-stable carmine” is not the ammonium salt of carminic acid, which is approved as food additive in the European Union. In fact, nitrogen in “acid-stable carmine” is covalently bound. The molecular structure of carminic acid is chemically modified and 4-aminocarminic acid does not comply with the specifications laid down for E120 in Commission Regulation (EU) No 231/2012. 4-Aminocarminic acid was also detected in the red-colored glaze of a raspberry cake and in the liquid dye preparation used for coloring this glaze.     

Schädigungsentwicklung der Legierung IN 738 LC bei Hochtemperatur-LCF-Beanspruchung

Damage evolution of the alloy IN 738 LC at high temperature low cycle fatigue Herrn Professor K.-T. Rie zum 60. Geburtstag Interrupted Low-Cycle-Fatigue tests have been carried out with IN 738 LC at 850°C. The specimens were extensively examined by SEM to quantify the evolution of fatigue damage. Surface crack nucleation at oxidized grain boundaries occured during the whole experiments. The coalescence of cracks was the dominant mechanism which lead to macro crack evolution and the final fracture.     

Substituierte Alkinyle als axiale Liganden an häminähnlich gebundenem Eisen(III) - Einordnung in eine spektrochemische Serie

Substituted Alkinyles as Axial Ligands at Hemine Like Bound Iron(III) - Incorporation into a Spectrochemical Series . Substituted lithium alkynyles Li CC R (R = ^tBu, Ph, p-Cl C₆H₄, Me₃Si, ⁱPr₃Si, Ph₃Si) react with the hemine like macrocyclic iron(III) complex 6,13-di(ethoxycarbonyl)-5, 14-dimethyl-1, 4, 8, 11-tetraazatetradeca-4,6,12,14-tetraenato[2⁻]iron(III)-iodide (formula 2 ;) in tetrahydrofuran to form anionic low-spin di-adducts [fe(CC R)₂]⁻. The incorporation of the alkynyles into a spectrochemical series of the axial ligands (studied by the sharp equatorial-ligand-to-metal CT absorption band) results in the wavelength-sequence (nm): OH⁻ (≈︁ 510) « N₃⁻ (≈︁ 625) < ^tBu CC⁻ (664) < NH₃ (666) < Ph CC⁻ (692) < Ph NH₂ (695) < Me₃Si CC⁻ (698) < SCN⁻ (713) < Ph₃Si C  C⁻ (716) < CN⁻ (739) < 4-picoline (759) < pyridine (765) < nicotinamide (776) < methylnicotinat (788) < pyrazine (798) and points to a significant π-acceptor ability of the silyl substituents.     

COVID-19 and Lung Mast Cells: The Kallikrein–Kinin Activation Pathway

Mast cells (MCs) have relevant participation in inflammatory and vascular hyperpermeability events, responsible for the action of the kallikrein–kinin system (KKS), that affect patients inflicted by the severe form of COVID-19. Given a higher number of activated MCs present in COVID-19 patients and their association with vascular hyperpermeability events, we investigated the factors that lead to the activation and degranulation of these cells and their harmful effects on the alveolar septum environment provided by the action of its mediators. Therefore, the pyroptotic processes throughout caspase-1 (CASP-1) and alarmin interleukin-33 (IL-33) secretion were investigated, along with the immunoexpression of angiotensin-converting enzyme 2 (ACE2), bradykinin receptor B1 (B1R) and bradykinin receptor B2 (B2R) on post-mortem lung samples from 24 patients affected by COVID-19. The results were compared to 10 patients affected by H1N1pdm09 and 11 control patients. As a result of the inflammatory processes induced by SARS-CoV-2, the activation by immunoglobulin E (IgE) and degranulation of tryptase, as well as Toluidine Blue metachromatic (TB)-stained MCs of the interstitial and perivascular regions of the same groups were also counted. An increased immunoexpression of the tissue biomarkers CASP-1, IL-33, ACE2, B1R and B2R was observed in the alveolar septum of the COVID-19 patients, associated with a higher density of IgE⁺ MCs, tryptase⁺ MCs and TB-stained MCs, in addition to the presence of intra-alveolar edema. These findings suggest the direct correlation of MCs with vascular hyperpermeability, edema and diffuse alveolar damage (DAD) events that affect patients with a severe form of this disease. The role of KKS activation in events involving the exacerbated increase in vascular permeability and its direct link with the conditions that precede intra-alveolar edema, and the consequent DAD, is evidenced. Therapy with drugs that inhibit the activation/degranulation of MCs can prevent the worsening of the prognosis and provide a better outcome for the patient.     

Potential Pro-Inflammatory Effect of Vitamin E Analogs through Mitigation of Tetrahydrocannabinol (THC) Binding to the Cannabinoid 2 Receptor

Vitamin E acetate, which is used as a diluent of tetrahydrocannabinol (THC), has been reported as the primary causative agent of e-cigarette, or vaping, product use-associated lung injury (EVALI). Here, we employ in vitro assays, docking, and molecular dynamics (MD) computer simulations to investigate the interaction of vitamin E with the membrane-bound cannabinoid 2 receptor (CB2R), and its role in modulating the binding affinity of THC to CB2R. From the MD simulations, we determined that vitamin E interacts with both CB2R and membrane phospholipids. Notably, the synchronized effect of these interactions likely facilitates vitamin E acting as a lipid modulator for the cannabinoid system. Furthermore, MD simulation and trajectory analysis show that when THC binds to CB2R in the presence of vitamin E, the binding cavity widens, facilitating the entry of water molecules into it, leading to a reduced interaction of THC with CB2R. Additionally, the interaction between THC and vitamin E in solution is stabilized by several H bonds, which can directly limit the interaction of free THCs with CB2R. Overall, both the MD simulations and the in vitro dissociation assay results indicate that THC binding to CB2R is reduced in the presence of vitamin E. Our study discusses the role of vitamin E in limiting the effect of THCs and its implications on the reported pathology of EVALI.     

Microcrystalline silicon films and solar cells deposited by PECVD and HWCVD

The application of microcrystalline silicon (μc-Si:H) in thin-film solar cells is addressed in the present paper. Results of different technologies for the preparation of μc-Si:H are presented, including plasma enhanced chemical vapour deposition (PECVD) using 13.56 MHz (radio frequency, rf) and 94.7 MHz (very high frequency, vhf) and hot-wire chemical vapour deposition (HWCVD). The influence of the silane concentration (SC) on the material and solar cell parameters is studied for the different techniques as the variation of SC allows to optimise the solar cell performance in each deposition regime. The best performance of μc-Si:H solar cells is always observed near the transition to amorphous growth. The highest efficiency obtained so far at a deposition rate of 5 Å/s is 9.4%, achieved with rf-PECVD in a deposition regime of using high pressure and high discharge power. High deposition rates and solar cell efficiencies could be also achieved by vhf-PECVD. An alternative approach represents the HWCVD which also demonstrated high deposition rates for μc-Si:H. However, good material quality and solar cell performance could only be achieved at low substrate temperatures and, consequently, low deposition rates. The μc-Si:H solar cells prepared by HWCVD exhibit comparably high efficiencies up to 9.4% and exceptionally high open circuit voltages up to 600 mV but at lower deposition rates (≈1 Å/s). The properties of PECVD and HWCVD solar cells are carefully compared.     

The un-utilizability design method for collector-storage walls

The monthly-average auxiliary energy requirement of a building with a collector-storage (Trombe) wall is estimated using upper and lower theoretical limits to system performance. These two limits on the building auxiliary energy requirements result from considering the building and collector-storage wall to have either zero thermal capacity or infinite thermal capacity. With zero thermal capacity, all solar gain in excess of the load, on an instantaneous basis, is not useful and must be dumped. With infinite thermal capacity, the house is able to store any gain in excess of the instantaneous load and use it at some later time. Auxiliary energy use by real systems will fall between these two theoretical bounds. An empirical correlation is presented for the fraction of the load met by the collector-storage wall, F, for systems with finite capacity. The correlation is based on the solar radiation statistic, utilizability. The correlation is compared to yearly TRNSYS simulation results for a wide variety of system types. The root-mean-square difference between F found from the un-utilizability method and from TRNSYS simulations is less than 4 per cent. One advantage of this method over other simplified design methods is that this method covers a much larger range of design parameters.